Experimental Experimental Methods
cocktail (95% TFA, 2.5% water, and 2.5% TIPS) concomitant with deprotection of lysine's -amino-Boc groups to give Fmoc-PEG-FFKLVFF conjugates; for part two after the Fmoc protecting group was removed by a solution of 20% piperidine/NMP, it was submitted to cleavage reaction to generate PEG-FFKLVFF conjugates. In the cleavage reaction, the mixture was stirred at room temperature for approximately 4 h and filtered. The obtained solution was concentrated and precipitated in cold diethyl ether and the crude product was separated by centrifugation and decanting the supernatant. Semi-preparative reverse phase HPLC (Perkin Elmer 200) was used for purification of the product and the following HPLC condition was employed: the eluents were 0.1% TFA in HPLC grade water and 0.1% TFA acetonitrile; during HPLC process a gradient solvent was used, where the acetonitrile portion increased linearly from 0% to 90% over 20 min and then decreased linearly to 0% over 10 min. 
Synthesis of Peptide n5-Fmoc

Synthesis of Peptide n27-Fmoc
to-detector distance was 1.2 m and the X-ray wavelength was  = 0.995 Å. The q = 4sin/ scale (here 2 is the scattering angle) was calibrated using silver behenate.
The same configuration was used to obtain in situ WAXS data, recorded using a linear AVIEX PCCD-4284 CCD detector. SI Fig.2 . SAXS data for 1 wt% solutions of PEG-FFKLVFF conjugates. At low q the scattering profiles for n5 and n11 show the scaling behaviour q -2 expected for sheetlike objects whereas for n27, a q -1 scaling is observed, consistent with cylindrical fibrils.
